Reliable Compounding Pharmacy Recalls All TRIE Products Due to Processing Controls
Reliable Compounding Pharmacy is recalling all TRIE products because of a lack of processing controls. The recall covers lots compounded between March 24, 2015, and March 24, 2016.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or illnesses are reported in the source text.
Plain-English summary
Reliable Rexall-A Compounding Pharmacy is recalling all TRIE products, which are prescription-only items compounded by the pharmacy located in San Francisco, California. The recall is being conducted due to a lack of processing controls.
The affected products include all lots compounded between March 24, 2015, and March 24, 2016, provided they are within their expiration dates. The distribution pattern includes the United States, specifically California, Hawaii, and New Mexico.
Consumers who have these products should stop using them and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- All TRIE Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.
- Manufacturer
- Reliable Rexall-A Compounding Pharmacy
- Category
- Drug — Compounded Prescription
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots compounded between 03/24/2015 and 03/24/2016 and within expiry.
Distribution
Part of a larger recall action
This product is one of 70 recalled by Reliable Rexall-A Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 70 products in this recall →Related recalls
Same manufacturer · Reliable Rexall-A Compounding Pharmacy
See all →- HighReliable Compounding Pharmacy Recalls Diltiazem Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Compounded All Midrin Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Compounded Monobenzone Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Quinacrine Products Due to Processing Control Deficiencies
FDA (Drugs) · 2016-07-13
- Moderate
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 11.24 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
Similar recalls
- SevereSpecialty Compounding Recalls All Prescription Products Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereTri-Mix Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereWell Care Compounding Pharmacy Recalls TRI-MIX # 1 Due to Sterility Concerns
FDA (Drugs) · 2016-06-15
- SevereFDA Recalls Tri-Mix Super Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereUS Compounding Recalls Bi-Mix Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereCompounded Tri-Mix Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23